AMERICAN CAPITAL GROUP

Lobbying Spend

—

Filings

Firms Hired

Active Period

2005–2007

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2007	—	3	1
2006	—	2	1
2005	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FOLEY HOAG LLP	—	8

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	5
SENATE	5
Health & Human Services, Dept of (HHS)	3
Centers For Medicare and Medicaid Services (CMS)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	5
Health Issues	Health Issues	2
Budget/Appropriations	Budget/Appropriations	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2900110th Congress

Food and Drug Administration Amendments Act of 2007

2007 · mid_year · Firm: FOLEY HOAG LLP

Cited source text and reported amounts

Drug safety legislation, S 1082, HR 2900 Critical Path Initiative

Client expense: — · Firm income: $20,000

Matched citations: HR 2900

AMERICAN CAPITAL GROUP — Lobbying Disclosure | Poliscope